| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.091 | 0.07 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.08 | 0.1 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.077 | 0.1 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.072 | 0.1 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.064 | 0.2 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.049 | 0.3 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.047 | 0.4 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.04 | 0.4 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.033 | 0.5 |